Topics

CNS Tumors | Etiopathogenesis | Gut–Brain Axis

Home > Publications > Topics > CNS Tumors > Etiopathogenesis > Gut–Brain Axis

Yang J, Lu J, Dong Y, Wei Y, Christian M, Huang J, Kuang H, Cao D.
Revealing the link between gut microbiota and brain tumor risk: a new perspective from Mendelian randomization.
Front Cell Infect Microbiol. 2024 Aug 6;14:1404745. doi: 10.3389/fcimb.2024.1404745. PMID: 39165915. Observational study. ˍ

Hoogendijk R, Geurts M, van der Lugt J.
Correlative Studies In Central Nervous System Tumors Clinical Trials: The Emerging Role Of Microbiome Research.
Neuro Oncol. 2025 Apr 30:noaf111. doi: 10.1093/neuonc/noaf111. PMID: 40305456. Editorial. ˍ

BharathwajChetty B, Kumar A, Deevi P, Abbas M, Alqahtani A, Liang L, Sethi G, Liu L, Kunnumakkara AB.
Gut microbiota and their influence in brain cancer milieu.
J Neuroinflammation. 2025 May 1;22(1):129. doi: 10.1186/s12974-025-03434-2. PMID: 40312370 Review. ˍ

Scuderi SA, Ardizzone A, Calcaterra E, Palermo N, De Luca F, Catalfamo A, Esposito E, Capra AP.
The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.
Biomedicines. 2025 Sep 5;13(9):2172. doi: 10.3390/biomedicines13092172. PMID: 41007735. Review. ˍ

Xu W, Xu Q, Luo P, Qu X, Guo D, Xie Z, Hang N, Kuang M, Chen E, Wang L, Yan Z, Cai S, Mao W, Tang B.
Gut-Brain-Microbiome Axis in the Regulation of Cancer Immune Escape and Immunotherapy in Tumors.
Research (Wash D C). 2025 Sep 11;8:0885. doi: 10.34133/research.0885. PMID: 40948940. Review. ˍ